The aim of our study was to investigate the effect of imatinib on two endothelial functions involved in type 2 diabetes: insulin-stimulated vasodilation of resistance arteries and endothelial fatty acid uptake. This evidence concerns the gene INS and type 2 diabetes mellitus.